202 related articles for article (PubMed ID: 31099973)
1. von Willebrand factor in experimental malaria-associated acute respiratory distress syndrome.
Kraisin S; Verhenne S; Pham TT; Martinod K; Tersteeg C; Vandeputte N; Deckmyn H; Vanhoorelbeke K; Van den Steen PE; De Meyer SF
J Thromb Haemost; 2019 Aug; 17(8):1372-1383. PubMed ID: 31099973
[TBL] [Abstract][Full Text] [Related]
2. Experimental malaria-associated acute respiratory distress syndrome is dependent on the parasite-host combination and coincides with normocyte invasion.
Vandermosten L; Pham TT; Possemiers H; Knoops S; Van Herck E; Deckers J; Franke-Fayard B; Lamb TJ; Janse CJ; Opdenakker G; Van den Steen PE
Malar J; 2018 Mar; 17(1):102. PubMed ID: 29506544
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor increases in experimental cerebral malaria but is not essential for late-stage pathogenesis in mice.
Kraisin S; Martinod K; Desender L; Pareyn I; Verhenne S; Deckmyn H; Vanhoorelbeke K; Van den Steen PE; De Meyer SF
J Thromb Haemost; 2020 Sep; 18(9):2377-2390. PubMed ID: 32485089
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of malaria liver pathology in mice infected with Plasmodium chabaudi AS or Plasmodium berghei NK65.
Scaccabarozzi D; Deroost K; Corbett Y; Lays N; Corsetto P; Salè FO; Van den Steen PE; Taramelli D
Malar J; 2018 Jan; 17(1):18. PubMed ID: 29316914
[TBL] [Abstract][Full Text] [Related]
5. A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.
O'Regan N; Gegenbauer K; O'Sullivan JM; Maleki S; Brophy TM; Dalton N; Chion A; Fallon PG; Grau GE; Budde U; Smith OP; Craig AG; Preston RJ; O'Donnell JS
Blood; 2016 Mar; 127(9):1192-201. PubMed ID: 26511133
[TBL] [Abstract][Full Text] [Related]
6. Release of endothelial activation markers in lungs of patients with malaria-associated acute respiratory distress syndrome.
Pham TT; Punsawad C; Glaharn S; De Meyer SF; Viriyavejakul P; Van den Steen PE
Malar J; 2019 Dec; 18(1):395. PubMed ID: 31796023
[TBL] [Abstract][Full Text] [Related]
7. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
8. Skeleton binding protein-1-mediated parasite sequestration inhibits spontaneous resolution of malaria-associated acute respiratory distress syndrome.
Possemiers H; Pham TT; Coens M; Pollenus E; Knoops S; Noppen S; Vandermosten L; D'haese S; Dillemans L; Prenen F; Schols D; Franke-Fayard B; Van den Steen PE
PLoS Pathog; 2021 Nov; 17(11):e1010114. PubMed ID: 34843584
[TBL] [Abstract][Full Text] [Related]
9. Altered Lipid Composition of Surfactant and Lung Tissue in Murine Experimental Malaria-Associated Acute Respiratory Distress Syndrome.
Scaccabarozzi D; Deroost K; Lays N; Omodeo Salè F; Van den Steen PE; Taramelli D
PLoS One; 2015; 10(12):e0143195. PubMed ID: 26624290
[TBL] [Abstract][Full Text] [Related]
10. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
Larkin D; de Laat B; Jenkins PV; Bunn J; Craig AG; Terraube V; Preston RJ; Donkor C; Grau GE; van Mourik JA; O'Donnell JS
PLoS Pathog; 2009 Mar; 5(3):e1000349. PubMed ID: 19300493
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria.
de Mast Q; Groot E; Asih PB; Syafruddin D; Oosting M; Sebastian S; Ferwerda B; Netea MG; de Groot PG; van der Ven AJ; Fijnheer R
Am J Trop Med Hyg; 2009 Mar; 80(3):492-8. PubMed ID: 19270304
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
[TBL] [Abstract][Full Text] [Related]
13. A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers.
O'Brien LA; Sutherland JJ; Hegadorn C; Benford K; Racz H; Rapson D; Hough C; Lillicrap D
J Thromb Haemost; 2004 Jul; 2(7):1135-42. PubMed ID: 15219197
[TBL] [Abstract][Full Text] [Related]
14. Integrin αDβ2 (CD11d/CD18) mediates experimental malaria-associated acute respiratory distress syndrome (MA-ARDS).
de Azevedo-Quintanilha IG; Vieira-de-Abreu A; Ferreira AC; Nascimento DO; Siqueira AM; Campbell RA; Teixeira Ferreira TP; Gutierrez TM; Ribeiro GM; E Silva PM; Carvalho AR; Bozza PT; Zimmerman GA; Castro-Faria-Neto HC
Malar J; 2016 Jul; 15(1):393. PubMed ID: 27473068
[TBL] [Abstract][Full Text] [Related]
15. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
[TBL] [Abstract][Full Text] [Related]
16. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
[TBL] [Abstract][Full Text] [Related]
17. Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage.
Wan H; Wang Y; Ai J; Brathwaite S; Ni H; Macdonald RL; Hol EM; Meijers JCM; Vergouwen MDI
J Thromb Haemost; 2018 Jul; 16(7):1413-1422. PubMed ID: 29729651
[TBL] [Abstract][Full Text] [Related]
18. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
[TBL] [Abstract][Full Text] [Related]
19. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
20. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
